Investing

Collegium Pharmaceutical : COLL

COLL

Stock Data

$34.32

$0.59 (1.75%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

DRUG MANUFACTURERS - SPECIALTY & GENERIC

Collegium Pharmaceutical Inc specializes in creating innovative pain management medications. Their product lineup features Xtampza ER, a unique formulation designed to deter abuse while providing extended pain relief, and Nucynta, available in both extended and immediate-release versions for various pain intensities. They also offer Belbuca, a buprenorphine-based film for pain management, and Symproic, aimed at treating opioid-induced constipation in adults. Founded in 2002 and based in Stoughton, Massachusetts, Collegium is dedicated to improving the lives of people dealing with chronic pain.

All Collegium Pharmaceutical Articles

1 Article

Ian Cooper | Oct 31, 2025 at 10:18 AM EDT

3 Explosive Stocks With High Short Interest

Short interest is always a sign of how bearish investors may be on a stock. But it can also serve…